Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Why Sartorius Stedim Biotech’s NanoSpark deal could be the missing link in scalable NK cell therapies Find out how Sartorius Stedim Biotech’s NanoSpark partnership and US$3M stake in Nanotein could reshape cell therapy manufacturing—read the full analysis. byPallavi MadhirajuAugust 11, 2025